Potassium Citrate Anhydrous

CHEMBL1200458 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
306.4 g/mol
LogP
Phase
4

A anhydrous form of potassium citrate with the same therapeutic properties. Used to prevent kidney stones by making the urine less acidic, which reduces the formation of certain types of stones, and also used in people with kidney disease to treat a condition where the blood becomes too acidic.

Moleküler Ağırlık

306,3900 g/mol

TPSA

141,00 Ų

Terapötik Alanlar

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[K+].[K+].[K+]

InChI

InChI=1S/C6H8O7.3K/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;/q;3*+1/p-3

Molecular Formula

C6H5K3O7

HBD / HBA

1 / 7

Döndürülebilir Bağlar

2

Ağır Atomlar

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A anhydrous form of potassium citrate with the same therapeutic properties. Used to prevent kidney stones by making the urine less acidic, which reduces the formation of certain types of stones, and also used in people with kidney disease to treat a condition where the blood becomes too acidic.

Yes, Potassium Citrate Anhydrous is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200458. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 13344. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.